Research

James Crowe Jr., MD, and colleagues are exploring how the body’s immune system gears up to fight off infection.

Vanderbilt vaccine pioneer James Crowe honored with major science prize

James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, will be honored today by the science and technology company Merck KGaA, Darmstadt, Germany for his contributions to developing new therapeutics and vaccines against some of the world’s deadliest viruses.

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Former Pharmacology chair Hardman remembered as gifted scientist, educator, mentor

Joel Hardman, PhD, an internationally recognized scientist and educator who chaired the Department of Pharmacology at Vanderbilt University School of Medicine from 1975 to 1990, died June 30, 2019 in Hoosick Falls, New York, after a lengthy illness. He was 85.

Benzodiazepine use with opioids intensifies neonatal abstinence syndrome

Babies born after being exposed to both opioids and benzodiazepines before birth are more likely to have severe drug withdrawal, requiring medications like morphine for treatment, compared to infants exposed to opioids alone.

Biomarkers of DNA methylation can be a predictor of breast cancer risk

Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk.

David Morrison, MD, and colleagues are studying whether to implant an artificial intraocular lens or fit a contact lens over a baby’s cornea after cataract surgery.

Study explores treatment options for babies with cataracts

Cataracts are uncommon in babies but when they occur the cloudy lenses must be removed without delay or blindness may result.

1 92 93 94 95 96 136